Vimarsana
Biggest News Aggregation in the World

Page 35 - Drug Pricing Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Pricing Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Pricing Program Today - Breaking & Trending Today

HHS must stop 340B cuts through 2022, judge rules - Vimarsana News

HHS must stop 340B cuts through 2022, judge rules

The district court ruling follows a Supreme Court decision against HHS restrictions on the 340B drug discount program for safety net providers.

How Bon Secours allegedly exploited a government drug program for profit - Vimarsana News

How Bon Secours allegedly exploited a government drug program for profit

Bon Secours bought deeply discounted drugs meant for low-income patients at Richmond Community and dispensed them at facilities throughout the area.

Virginia senator calls NYT investigation into Bon Secours 'troubling' - Vimarsana News

Virginia senator calls NYT investigation into Bon Secours 'troubling'

The New York Times investigation alleges Bon Secours is failing to use the savings to help underserved populations, putting new scrutiny on the program.

Source: wtvr.com
New Data Shows Largest "Non-Profit" 340B Hospitals Charge Privately Insured Patients Extreme Markups for Cancer Drugs - US Politics Today - Vimarsana News

New Data Shows Largest "Non-Profit" 340B Hospitals Charge Privately Insured Patients Extreme Markups for Cancer Drugs - US Politics Today

COA Examination of 340B Data Indicates Hospitals Charge Markups of 4.9 Times to Insured Patients, Do Not Pass on Discounts to Patients in Need

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Patients - Vimarsana News

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Patients

Nation’s largest hospitals, pharmacy benefit managers (PBMs), and pharmacies abuse drug discount program to pocket savings intended for uninsured patients